Fed Study of Nadolol/Bendroflumethiazide Tablets 80 mg/5 mg and Corzide® Tablets 80 mg/5 mg
Clinical trial NCT00648297 · COMPLETED
Trial details
- NCT number
- NCT00648297
- Sponsor
- Mylan Pharmaceuticals Inc
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2006-08-01
- Primary completion
- 2006-08-01
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.